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A52-year-oldfemalepresentedwithidiopathicstocking-gloveneuropathy.Sheunderwentaseriesofrightandleftstellateganglion
blocks with ropivacaine and clonidine, followed by lumbar sympathetic blocks. This resulted in complete symptom relief for two
weeks.Theseprocedureswererepeatedafteratwo-monthinterval;atthattimeshewasstillexperiencingpartialrelieffromtheﬁrst
series. She again remained completely pain free for several weeks following the injections. As the pain partially returned, daily oral
clonidine was initiated and resulted in almost complete cessation of her symptoms, which persisted at a three-month follow-up
examination.
1.Introduction
Peripheral neuropathy can be a debilitating neurologic dis-
ease that presents a challenge in chronic pain management.
The prevalence of peripheral neuropathy has been reported
in the general population to range from 2.4 to 8.0 percent
with a higher prevalence in the elderly [1]. Patients usually
present with complaints of burning pain in the distal
upper and lower extremities [1]. They may also experience
numbness or tingling, weakness, hyporeﬂexia, muscle atro-
phy, or hypersensitivity in the distribution of their pain
[1, 2]. The diﬀerential diagnosis for this disease is broad and
includes inherited disorders and a host of chronic illnesses
suchasdiabetesandleprosy[1,2].Othercausesofperipheral
neuropathy include traumatic injury, vitamin deﬁciency,
infection, toxins, and medication side eﬀects [1, 2]. The
medicaltesting requiredtodiﬀerentiate between these causes
can be time consuming and may still not reveal a diagnostic
cause in up to 25 percent of patients [1].
2.CaseDescription
The patient was a 52-year-old female with a history of
bipolar disorder and smoking who presented with idio-
pathic stocking-glove neuropathy. Prior to the onset of her
symptoms she had undergone a C5-C6 anterior fusion for
cervical radiculopathy. A complete rheumatologic workup
to determine the cause of her neuropathy was negative. An
electromyogram showed no evidence of radiculopathy or
neuropathy. A cervical MRI revealed chronic ﬂattening of
the spinal cord, but the patient had no clinical evidence of
myelopathy such as sensory or motor deﬁcits on physical
exam. Previous treatment strategies included unsuccessful
carpel tunnel and trigger thumb release. On initial presenta-
tion her medications included methadone 10mg twice daily
and oxycodone 60mg four times daily as needed; however,
she continued to rate her pain as a 9 out of 10 in severity.
The patient was originally treated with a right stellate
ganglion block containing ropivacaine and clonidine. This
was performed under ﬂuoroscopic guidance by injecting
local anesthetic at the junction of the C6 uncinate process
and vertebral body [3], creating a sympathectomy to the
head, neck, and upper extremities. This intervention resulted
in complete symptom relief in her right upper extremity for
two weeks. The patient then underwent left stellate ganglion
block with similar results in her left-upper extremity.
Given the successful treatment of her upper extremity
peripheral neuropathy with sympathetic blockade, a trial
of lumbar sympathetic blockade was initiated in her lower
extremities.Lumbarsympatheticblockadewasperformedby2 Case Reports in Anesthesiology
injection at the anterolateral surface of L2-L3 vertebral bod-
ies [4]. Each side of the sympathetic blockade was separated
by a time frame of approximately two weeks. Both lumbar
sympathetic blocks produced symptom relief for approxi-
mately two weeks similar to the upper extremity blockade.
These procedures were repeated after a two-month interval.
At that time, she was still experiencing partial relief from
the ﬁrst series. She again remained completely pain free for
several weeks following the injections.
As the pain partially returned, pregabalin was added to
her medication regimen. However, she experienced sedation
and dizziness which required discontinuation. Twice daily
oral clonidine 0.1mg was then initiated and resulted in
almost complete cessation of her symptoms of peripheral
neuropathy.
3. Discussion
Sympathetic nerve blockade of the upper and lower extrem-
ities is the treatment of choice for severe, sympathetically
mediated pain that cannot be managed appropriately with
oral regimens [5] and serves as a diagnostic and therapeutic
intervention for sympathetically mediated pain [4–6]. A spe-
ciﬁc type of sympathetic block, stellate ganglion blockade, is
used for many chronic pain syndromes that involve the head
and upper extremities [5, 6]. It has been used to treat com-
plex regional pain syndrome (CRPS) I and II, vascular insuf-
ﬁciency,lymphedema,postherpeticneuralgia,phantomlimb
pain, acute hearing loss, hyperhidrosis, vascular-mediated
headache and neuropathic pain [5, 6]. The indications
for lumbar sympathetic blockade are similar but involve
pain distributed in the lower extremities. They include CRPS
of the lower extremities, phantom limb pain, postherpetic
neuralgia, and vascular insuﬃciency including peripheral
arteriosclerotic disease [4, 5].
The patient had a more prolonged response to sympa-
thetic blockade than expected given the rapid metabolism
of local anesthetics and clonidine. This suggests that a
brief interruption of the sympathetic chain may have a
prolonged eﬀect on sympathetic neural ﬁring. In addition
to sympathetic blockade, a reduction in sympathetic tone by
adding clonidine to her medical regimen seemed to have a
durable therapeutic eﬀect on her sympathetically mediated
pain.
Clonidine is an alpha-2 agonist originally used in the
treatment of hypertension which has recently gained pop-
ularity in the treatment of perioperative and chronic pain.
Clonidine’s role as an analgesic is based on experimental
studies showing that it augments hyperpolarization based
on the frequency of neuronal ﬁring [7]. The addition of
clonidine to prolong peripheral nerve blockade has been
demonstrated in several clinical trials [7]. In recent studies,
doses of systemic clonidine in 4µg/kg have been shown
to decrease opioid requirement without signiﬁcant cardio-
vascular eﬀects [7]. The role of clonidine in chronic pain
management has been less studied but may play a role as an
adjuvant to more traditional medical regimens.
The treatment of idiopathic peripheral neuropathy can
presentachallengetothepainphysician.Thiscasehighlights
the role of sympathetic blockade and oral pain regimens
focused on treating sympathetically mediated pain. If the
physician suspects that these debilitating symptoms have
a sympathetic component based on the inciting event or
patient history, treatment with sympathetic blockade and
clonidine may be of beneﬁt when more traditional medical
management alone is not suﬃcient.
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